Targeting cGAS-STING pathway is a promising strategy in tumor treatment. The pattern recognition receptor cGAS identifies dsDNA and catalyzes the formation of the second messenger 2'3'-cGAMP, activating the downstream interferons and pro-inflammatory cytokines through the adaptor protein STING. Notably, in tumor immune microenvironment, key components of cGAS-STING pathway are transferred among neighboring cells. The intercellular transmission under these contexts serves to sustain and amplify innate immune responses while facilitating the emergence of adaptive immunity. The membrane-based system, including extracellular vesicles transport, phagocytosis and membrane fusion transmit dsDNA, cGAMP and activated STING, enhancing the immune surveillance and inflammatory. The membrane proteins, including specific protein channel and intercellular gap junctions, transfer cGAMP and dsDNA, which are crucial to regulate immune responses. And the ligand-receptor interactions for interferons transmission amplifies the anti-tumor response. This review elaborates on the regulatory mechanisms of cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment. We further explore how these mechanisms modulate immunological processes and discuss potential interventions and immunotherapeutic strategies targeting these signaling cascades.

Tumor cells adaptively reforge their metabolism to meet the demands of energy and biosynthesis. Mitochondria, pivotal organelles in the metabolic reprogramming of tumor cells, contribute to tumorigenesis and cancer progression significantly through various dysfunctions in both tumor and immune cells. Alterations in mitochondrial dynamics and metabolic signaling pathways exert crucial regulatory influence on the activation, proliferation, and differentiation of immune cells. The tumor microenvironment orchestrates the activation and functionality of tumor-infiltrating immune cells by reprogramming mitochondrial metabolism and inducing shifts in mitochondrial dynamics, thereby facilitating the establishment of a tumor immunosuppressive microenvironment. Stress-induced leakage of mitochondrial DNA contributes multifaceted regulatory effects on anti-tumor immune responses and the immunosuppressive microenvironment by activating multiple natural immune signals, including cGAS-STING, TLR9, and NLRP3. Moreover, mitochondrial DNA-mediated immunogenic cell death emerges as a promising avenue for anti-tumor immunotherapy. Additionally, mtROS, a crucial factor in tumorigenesis, drives the formation of tumor immunosuppressive microenvironment by changing the composition of immune cells within the tumor microenvironment. This review focuses on the intrinsic relationship between mitochondrial biology and anti-tumor immune responses from multiple angles. We expect to explore the core role of mitochondria in the dynamic interplay between the tumor and the host, in order to facilitate the development of targeted mitochondrial strategies for anti-tumor immunotherapy.

cGAS-STING signaling is a significant component of the innate immune system and functions as a vital sentinel mechanism to monitor cellular and tissue aberrations in microbial invasion and organ injury. cGAS, a cytosolic DNA sensor, is specialized in recognizing abnormally localized cytoplasmic double-stranded DNA (dsDNA) and catalytically synthesizes the second messenger cyclic-GMP-AMP (cGAMP), which initiates a cascade of type I interferon and inflammatory responses mediated by STING. Micronucleus, a byproduct of chromosomal missegregation during anaphase, are also significant contributors to cytoplasmic dsDNA. These unstable subcellular structures are susceptible to irreversible nuclear envelope rupture, exposing genomic dsDNA to the cytoplasm, which potently recruits cGAS and activates STING-mediated innate immune signaling and its downstream activities, including type I interferon and classical nuclear factor-κB (NF-κB) signaling pathways lead to senescence, apoptosis, autophagy activating anti-cancer immunity or directly killing tumor cells. However, sustained STING activation-induced endoplasmic reticulum stress, activated chronic type I interferon and nonclassical NF-κB signaling pathways remodel immunosuppressive tumor microenvironment, leading to immune evasion and facilitating tumor metastasis. Therefore, activated cGAS-STING signaling plays a dual role of suppressing or facilitating tumor growth in tumorigenesis and therapy. This review elaborates on research advances in mechanisms of micronucleus inducing activation of cGAS-STING signaling and its implications in tumorigenesis and therapeutic strategies of malignant tumors.

Tumor cells adapt their metabolism to meet the demands for energy and biosynthesis.Mitochondria,pivotal organelles in the metabolic reprogramming of tumor cells,contribute to tumorigenesis and cancer progression significantly through various dysfunctions in both tumor and immune cells.Alterations in mitochondrial dynamics and metabolic signaling pathways exert crucial regulatory influence on the activation,proliferation,and differentiation of immune cells.The tumor microenvironment orchestrates the activation and functionality of tumor-infiltrating immune cells by reprogramming mitochondrial metabolism and inducing shifts in mitochondrial dynamics,thereby facilitating the establishment of a tumor immunosuppressive microenvironment.Stress-induced leakage of mitochondrial DNA contributes multifaceted regulatory effects on anti-tumor immune responses and the immunosuppressive microenvironment by activating multiple natural immune signals,including cGAS-STING,TLR9,and NLRP3.Moreover,mitochondrial DNA-mediated immunogenic cell death emerges as a promising avenue for anti-tumor immunotherapy.Additionally,mitochondrial reactive oxygen species,a crucial factor in tumorigenesis,drives the formation of tumor immunosuppressive microenvironment by changing the composition of immune cells within the tumor microenvironment.This review focuses on the intrinsic relationship between mitochondrial biology and anti-tumor immune responses from multiple angles.We explore the core role of mitochondria in the dynamic interplay between the tumor and the host to facilitate the development of targeted mitochondrial strategies for anti-tumor immunotherapy.

Targeting cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)-stimulator of interferon genes(STING)pathway is a promising strategy for tumor treatment.The pattern recognition receptor cGAS identifies dsDNA and catalyzes the formation of a second messenger 2′3′-cyclic guanosine monophosphate-adenosine monophosphate(cGAMP),activating the downstream interferons and pro-inflammatory cytokines through the adaptor protein STING.Notably,in tumor immune microenvironment,key components of cGAS-STING pathway are transferred among neighboring cells.The intercellular transmission under these contexts serves to sustain and amplify innate immune responses while facilitating the emergence of adaptive immunity.The membrane-based system,including extracellular vesicles transport,phagocytosis and membrane fusion transmit dsDNA,cGAMP and activated STING,enhances the immune surveillance and inflammatory responses.The membrane proteins,including a specific protein channel and intercellular gap junctions,transfer cGAMP and dsDNA,which are crucial to regulate immune responses.The ligand-receptor interactions for interferon transmission amplifies the anti-tumor response.This review elaborates on the regulatory mechanisms of cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment,explores how these mechanisms modulate immunological processes and discusses potential interventions and immunotherapeutic strategies targeting these signaling cascades.

Cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)-stimulator of interferon genes(STING)signaling is a significant component of the innate immune system and functions as a vital sentinel mechanism to monitor cellular and tissue aberrations in microbial invasion and organ injury.cGAS,a cytosolic DNA sensor,is specialized in recognizing abnormally localized cytoplasmic double-stranded DNA(dsDNA)and catalyzes the formation of a second messenger cyclic-GMP-AMP(cGAMP),which initiates a cascade of type Ⅰ interferon and inflammatory responses mediated by STING.Micronucleus,a byproduct of chromosomal missegregation during anaphase,is also a significant contributor to cytoplasmic dsDNA.These unstable subcellular structures are susceptible to irreversible nuclear envelope rupture,exposing genomic dsDNA to the cytoplasm,which potently recruits cGAS and activates STING-mediated innate immune signaling and its downstream activities,including type Ⅰ interferon and classical nuclear factor-κB(NF-κB)signaling pathways lead to senescence,apoptosis,autophagy activating anti-cancer immunity or directly killing tumor cells.However,sustained STING activation-induced endoplasmic reticulum stress,activated chronic type Ⅰinterferon and nonclassical NF-κB signaling pathways remodel immunosuppressive tumor microenvironment,leading to immune evasion and facilitating tumor metastasis.Therefore,activated cGAS-STING signaling plays a dual role of suppressing or facilitating tumor growth in tumorigenesis and therapy.This review elaborates on research advances in mechanisms of micronucleus inducing activation of cGAS-STING signaling and its implications in tumorigenesis and therapeutic strategies of malignant tumors.

Innate nucleic acid sensing is a ubiquitous and highly conserved immunological process,which is pivotal for monitoring and responding to pathogenic invasion and cellular damage,and central to host defense,autoimmunity,cell fate determination and tumorigenesis.Tyrosine phosphorylation,a major type of post-translational modification,plays a critical regulatory role in innate immune sensing pathway.Core members of nucleic acid sensing signaling pathway,such as cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS),stimulator of interferon genes(STING),and TANK binding kinase 1(TBK1),are all subject to activity regulation triggered by tyrosine phosphorylation,thereby affecting the host antiviral defense and anti-tumor immunity under physiological or pathological conditions.This review summarizes the recent advances in research on tyrosine kinases and tyrosine phosphorylation in regulation of nucleic acid sensing.The function and potential applications of targeting tyrosine phosphorylation in anti-tumor immunity is disussed to provide insights for understanding and expanding new anti-tumor strategies.

Hepatocellular carcinoma(HCC)is a serious neoplastic disease with increasing incidence and mortality,accounting for 90%of all liver cancers.Hepatitis viruses are the major causative agents in the development of HCC.Hepatitis A virus(HAV)primarily causes acute infections,which is associated with HCC to a certain extent,as shown by clinicopathological studies.Chronic hepatitis B virus(HBV)or hepatitis C virus(HCV)infections lead to persistent liver inflammation and cirrhosis,disrupt multiple pathways associated with cellular apoptosis and proliferation,and are the most common viral precursors of HCC.Mutations in the HBV X protein(HBx)gene are closely associated with the incidence of HCC,while the expression of HCV core proteins contributes to hepatocellular lipid accumulation,thereby promoting tumorigenesis.In the clinical setting,hepatitis D virus(HDV)frequently co-infects with HBV,increasing the risk of chronic hepatitis.Hepatitis E virus(HEV)usually causes acute infections.However,chronic infections of HEV have been increasing recently,particularly in immuno-compromised patients and organ transplant recipients,which may increase the risk of progression to cirrhosis and the occurrence of HCC.Early detection,effective intervention and vaccination against these viruses may significantly reduce the incidence of liver cancer,while mechanistic insights into the interplay between hepatitis viruses and HCC may facilitate the development of more effective intervention strategies.This article provides a comprehensive overview of hepatitis viruses and reviews recent advances in research on aberrant hepatic immune responses and the pathogenesis of HCC due to viral infection.

As the understanding of the pathogenic mechanisms of gastric cancer deepens and the identification of gastric cancer driver genes advances,drugs targeting gastric cancer driver genes have been applied in clinical practice.Among them,trastuzumab,as the first targeted drug for gastric cancer,effectively inhibits the proliferation and metastasis of tumor cells by targeting overexpressed human epidermal growth factor receptor 2(HER2).Trastuzumab has become the standard treatment for HER2-positive gastric cancer patients.Ramucirumab,on the other hand,inhibits tumor angiogenesis by targeting vascular endothelial growth factor receptor 2(VEGFR2)and has been used as second-line therapy for advanced gastric cancer patients.In addition,bemarituzumab targets overexpressed fibroblast growth factor receptor 2(FGFR2),while zolbetuximab targets overexpressed claudin 18.2(CLDN18.2),significantly extending progression-free survival and overall survival in patients with gastric cancer in clinical trials.This article reviews the roles of tumor driver genes in the progression of gastric cancer,and the treatment strategies for gastric cancer primarily based on targeting HER2,VEGF,FGFR2,CLDN18.2 and MET.This provides a reference for clinical application of targeted therapy for gastric cancer.

Tumor cells adapt their metabolism to meet the demands for energy and biosynthesis.Mitochondria,pivotal organelles in the metabolic reprogramming of tumor cells,contribute to tumorigenesis and cancer progression significantly through various dysfunctions in both tumor and immune cells.Alterations in mitochondrial dynamics and metabolic signaling pathways exert crucial regulatory influence on the activation,proliferation,and differentiation of immune cells.The tumor microenvironment orchestrates the activation and functionality of tumor-infiltrating immune cells by reprogramming mitochondrial metabolism and inducing shifts in mitochondrial dynamics,thereby facilitating the establishment of a tumor immunosuppressive microenvironment.Stress-induced leakage of mitochondrial DNA contributes multifaceted regulatory effects on anti-tumor immune responses and the immunosuppressive microenvironment by activating multiple natural immune signals,including cGAS-STING,TLR9,and NLRP3.Moreover,mitochondrial DNA-mediated immunogenic cell death emerges as a promising avenue for anti-tumor immunotherapy.Additionally,mitochondrial reactive oxygen species,a crucial factor in tumorigenesis,drives the formation of tumor immunosuppressive microenvironment by changing the composition of immune cells within the tumor microenvironment.This review focuses on the intrinsic relationship between mitochondrial biology and anti-tumor immune responses from multiple angles.We explore the core role of mitochondria in the dynamic interplay between the tumor and the host to facilitate the development of targeted mitochondrial strategies for anti-tumor immunotherapy.